Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of benznidazole in adults with chronic Chagas disease
2011-002900-34Phase 4Completed
- Sponsor
- CRESIB
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of benznidazole in American trypanosomiasis (CD), sponsored by CRESIB. Primary endpoints: Population pharmacokinetics of benznidazole and Sources of interindividual pharmacokinetic variability. Started Dec 2011; status: completed.
02
Drugs
benznidazole
03
Conditions
American trypanosomiasis (CD)
Beyond the preview
Go deeper on 2011-002900-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002900-34.